Circulating nucleosomal DNA of blood as an indicator of the pathological process during chronical bronchitis

I. Vasilyeva, T. Ivtchik (Saint-Petersburg, Russian Federation)

Source: Annual Congress 2011 - Update on monitoring airway diseases
Session: Update on monitoring airway diseases
Session type: Thematic Poster Session
Number: 4030

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Vasilyeva, T. Ivtchik (Saint-Petersburg, Russian Federation). Circulating nucleosomal DNA of blood as an indicator of the pathological process during chronical bronchitis. Eur Respir J 2011; 38: Suppl. 55, 4030

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
Source: International Congress 2017 – Rare diseases
Year: 2017


Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013

Oxidative modification of proteins of blood plasma in patients with interstitial lung diseases
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Analysis of DNA repair synthesis in peripheral blood lymphocytes from patients with well-controlled and uncontrolled asthma
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


DNA damage as a molecular link in the pathogenesis of COPD in smokers
Source: Eur Respir J 2012; 39: 1368-1376
Year: 2012



Altered DNA methylation levels in the context of exposures and respiratory disease
Source: International Congress 2016 – Genetics, epigenetics and the exposome
Year: 2016


Blood mitochondrial DNA as a biomarker of clinical outcomes in idiopathic pulmonary fibrosis
Source: Eur Respir J, 56 (5) 2001769; 10.1183/13993003.01769-2020
Year: 2020



Effect of ultrafine particle matter on human peripheral blood mononuclear cells of chronic obstructive pulmonary disease patients: involvement of the inflammasome.
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017

Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019

Altered expression of long non-coding RNA in sputum and blood during pulmonary exacerbation in cystic fibrosis
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021


Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001

Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Biomarkers in peripheral blood from patients with chronic silicosis caused by artificial quartz agglomerates
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019

Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Relationship between arterial carboxyhemoglobin concentrations and other biological inflammatory indicators in patients with bacterial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 355s
Year: 2002

Plasma mitochondrial DNA as a biomarker of disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018



Characteristic of cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008

The content of soluble forms of activated molecules of leukocytes in the blood serum of patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004